Euroopa Liit - malta - EMA (European Medicines Agency)

pari pharma gmbh - tobramycin - respiratory tract infections; cystic fibrosis - antibatteriċi għal użu sistemiku, - vantobra huwa indikat għall-ġestjoni ta 'infezzjoni pulmonari minħabba pseudomonas aeruginosa fit-pazjenti ta' bejn 6 snin u akbar b'fibrożi ċistika (cf). għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Euroopa Liit - malta - EMA (European Medicines Agency)

juta pharma gmbh - pegfilgrastim - newtropenja - immunostimulanti, - tnaqqis fit-tul tal-neutropenia u l-inċidenza tal-marda bid-deni neutropenia fil-pazjenti adulti ttrattati ċitotossiċi chemotherapy għall-malignancy (bl-eċċezzjoni ta ' kronika myeloid lewċemja u myelodysplastic sindromi).

Euroopa Liit - malta - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - aġenti antineoplastiċi - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Euroopa Liit - malta - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - imblokk neuromuskolari - il-prodotti terapewtiċi l-oħra kollha - it-treġġigħ lura ta 'imblokk newromuskolari kkawżat minn rocuronium jew vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Euroopa Liit - malta - EMA (European Medicines Agency)

teva b.v.  - clopidogrel (as hydrochloride) - myocardial infarction; peripheral vascular diseases; stroke - aġenti antitrombotiċi - clopidogrel huwa indikat fl:pazjenti adulti li jbatu minn infart mijokardijaku (minn ftit jiem sa inqas minn 35 jum), puplesija iskemika (minn 7 ijiem sa inqas minn 6 xhur) jew mard arterjali periferali. pazjenti adulti li jsofru mis-sindromu koronarju akut:mhux elevazzjoni tas-segment st sindromu koronarju akut (anġina instabbli jew mhux-mewġa-q infart mijokardijaku), li jinkludu pazjenti fi proċess li titpoġġa stent wara intervent koronarju perkutanju, flimkien ma ' acetylsalicylic acid (asa). elevazzjoni tas-segment st infart mijokardijaku akut, flimkien ma ' asa f'medikament pazjenti kkurati b'eliġibbli għat-terapija trombolitika. il-prevenzjoni ta aterotrombotiċi u avvenimenti tromboemboliċi fil-fibrillazzjoni atrijali f'pazjenti adulti li jbatu minn fibrillazzjoni atrijali li jkollhom mill-inqas fattur ta 'riskju wieħed għall-episodji vaskulari, mhumiex adattati għall-kura bl-antagonisti tal-vitamina k (vka) u li għandhom baxx-riskju ta'fsada, clopidogrel huwa indikat, flimkien ma' asa għall-prevenzjoni tal-aterotrombotiċi u avvenimenti tromboemboliċi, inkluż puplesija.

Euroopa Liit - malta - EMA (European Medicines Agency)

n.v. organon - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - anti-istaminiċi għall-użu sistemiku, - aerius huwa indikat għas-serħan mis-sintomi assoċjati ma': rinite allerġika;urtikarja.

Euroopa Liit - malta - EMA (European Medicines Agency)

n.v. organon - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - anti-istaminiċi għall-użu sistemiku, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.

Euroopa Liit - malta - EMA (European Medicines Agency)

n.v. organon - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - anti-istaminiċi għall-użu sistemiku, - neoclarityn huwa indikat għas-serħan mis-sintomi assoċjati ma': allerġiċi rhinitisurticaria.

Euroopa Liit - malta - EMA (European Medicines Agency)

teva b.v.  - lamivudine - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - lamivudine teva pharma b. huwa indikat bħala parti ta ' terapija ta ' kombinazzjoni ta ' antiretroviral għat-trattament tal-bniedem-immunodefiċjenza-virus (hiv)-infettati adulti u tfal.

Euroopa Liit - malta - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - zoledronic acid - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - drogi għat-trattament ta 'mard tal-għadam - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. trattament ta ' osteoporożi assoċjat ma sistemiku fit-tul terapija bi glukokortikojdi fil-nisa wara l-menopawża u f'irġiel f'riskju akbar ta'ksur. it-trattament tal-marda ta'paget ta ' l-għadam.